Clinical Evaluation of a Novel Textile Radiation Protection Device

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEmory University

About this trial

This study will use procedure-specific dosimetry to evaluate whether Texray's novel woven radiation protection fabric (HeadPeace and MindPeace) reduces occupational radiation dose to the head and thyroid of interventional radiology personnel compared with standard radiation protection equipment, and to explore variation in efficacy by role, procedure type, and fluoroscopy room/equipment characteristics.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥18 years.

Employed or regularly working in the IR department at the study site.

Routinely present in fluoroscopy-guided procedures (e.g., IR attending, IR trainee, technologist, IR nurse, anesthesia provider).

Scheduled to work in procedure rooms equipped with Texray garments and dosimetry systems during the study period.

Disqualifiers

Age <18 years.

Not regularly present in IR suites during fluoroscopy-based procedures.

Known pregnancy at the time of enrollment.

Presence of a musculoskeletal or dermatologic condition that, in the opinion of the investigator or the participant, would prevent safe use of the Texray garments (e.g., inability to tolerate additional weight or fabric contact).

Trial design

Design model

Crossover

Treatments tested in this trial

  • Standard PPE

    Device

    Standard PPE (Baseline Phase): Participants wear their usual radiation protection equipment, including standard lead aprons and thyroid collars (and any head coverings they already use). Personal dosimeters are placed at predefined anatomical regions mimicking Texray coverage (e.g., forehead, temples, anterior/lateral thyroid) over standard PPE. These readings provide baseline scatter radiation exposure under current clinical conditions.

  • Texray PPE

    Device

    Texray PPE (Intervention Phase): During the intervention phase, participants wear HeadPeace (non-lead head protector) and MindPeace (non-lead thyroid and face protector) during procedures. Each garment includes internal and external dosimeter pockets at key anatomical sites to enable paired measurements beneath and outside the shield. These data support calculation of percent dose reduction and attenuation at specific sites.

Treatment groups

20 Participants
are divided into 2 treatment groups
Group A: Group A: Standard Personal Protective Equipment (PPE) only then Texray PPEExperimental treatment 2 interventions
Group B: Texray PPE then Standard PPE onlyExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Radiation dose comparing standard PPE vs. Texray PPE groups

Radiation dose to the head and thyroid region (mSv), as measured by personal dosimeters during fluoroscopy-guided procedures, comparing standard PPE vs. Texray PPE groups.

Time frame
Baseline, 4 and 8 weeks post-intervention

Secondary outcomes

1

Role-specific radiation dose

Role-specific radiation dose in mSv will be measured (attending IR, trainee, technologist, nurse, anesthesia) comparing standard PPE vs. Texray PPE groups.

Time frame
Baseline, 4 and 8 weeks post-intervention
2

Procedure-specific radiation dose

Procedure-specific radiation dose in mSv (e.g., liver-directed therapy, embolization, venography, line and port placement) will be measured comparing standard PPE vs. Texray PPE groups.

Time frame
Baseline, 4 and 8 weeks post-intervention
3

Radiation dose and attenuation stratified by fluoroscopy room

Radiation dose will be measured comparing standard PPE vs. Texray PPE groups stratified by fluoroscopy room and equipment age (new vs. legacy systems).

Time frame
Baseline, 4 and 8 weeks post-intervention
4

Number of participants with correct donning/doffing placement of the PPE

Number of participants with correct PPE donning/doffing will be recorded.

Time frame
Baseline, 4 and 8 weeks post-intervention

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: